Chromosome analysis of uterine adenomyosis Detection of the leiomyoma associated del(7q) in three cases

Nikos Pandis, N Pandis, Christos Karaiskos, C Karaiskos, G Bardi, Georgia Bardi, Kostas Sfikas, K Sfikas, Aliki Tserkezoglou, A Tserkezoglou, S Fotiou, Stelios Fotiou, S Heim, Sverre Heim
Cancer genetics and cytogenetics · 1995 · vol. 80(2) , pp. 118–120 · doi:10.1016/0165-4608(94)00176-c · PMID:7736427 · W2081538888
article OA: closed CC0 ⤵ 12 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

Chromosome analysis of uterine adenomyosis detected the leiomyoma-associated del(7q) chromosomal abnormality in three cases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715adenomyosis

MeSH descriptors

Chromosome Deletion Chromosomes, Human, Pair 7 Endometriosis Leiomyoma Uterine Neoplasms Adult Endometriosis Endometriosis Female Humans Karyotyping Leiomyoma Leiomyoma Middle Aged Uterine Neoplasms Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (5)

Cited by (12)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:11:13.665691+00:00
License: CC0 · commercial use OK